9RN-13045-46802
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 200 / DC
- Registered
- 2021-06-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-25
Registered in v-safe
-
2021-06-25
Dose 1 — Pfizer-BioNTech
-
2021-06-25
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-06-27
-
2021-07-16
Dose 2 — Pfizer-BioNTech
-
2021-08-08
Survey response — day 21, dose 2MedDRA: Anosmia, COVID-19, Cough, Headache, Myalgia, Pyrexia, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Contracted covid 3 weeks after 2nd dose - fever, headache, sinus infection, cough, sore muscles, complete loss of smellMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-08
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-11
-
2021-08-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-25 | Pfizer-BioNTech | No |
| 2 | 2021-07-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 21, dose 2
Symptoms: Contracted covid 3 weeks after 2nd dose - fever, headache, sinus infection, cough, sore muscles, complete loss of smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SD | Sinusitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release